{"name":"Lanthio Pharma","permalink":"lanthio-pharma","crunchbase_url":"http://www.crunchbase.com/company/lanthio-pharma","homepage_url":"http://www.lanthiopharma.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@lanthiopharma.com","phone_number":"31-50-363-5246","description":"","created_at":"Thu Nov 29 03:33:59 UTC 2012","updated_at":"Thu Nov 29 03:37:53 UTC 2012","overview":"<p>Lanthio Pharma is a privately held drug discovery company that applies its proprietary lanthionine-peptide drug discovery technology LanthioPepTM for the generation of novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity. Lanthio Pharma has generated stable, peptidase-resistant lanthionine peptides with highly specific agonistic activity for a number of GPCR targets, which is a focus area of the company.</p>","image":{"available_sizes":[[[150,75],"assets/images/resized/0022/2920/222920v1-max-150x150.jpg"],[[220,110],"assets/images/resized/0022/2920/222920v1-max-250x250.jpg"],[[220,110],"assets/images/resized/0022/2920/222920v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"€4.8M","funding_rounds":[{"round_code":"a","source_url":"http://www.finsmes.com/2012/11/lanthio-pharma-raises-e4-8m-close-series-funding.html","source_description":"Lanthio Pharma Raises €4.8M in First Close of Series A funding","raised_amount":4800000,"raised_currency_code":"EUR","funded_year":2012,"funded_month":11,"funded_day":28,"investments":[{"company":null,"financial_org":{"name":"BioGeneration Ventures","permalink":"biogeneration-ventures","image":{"available_sizes":[[[150,35],"assets/images/resized/0004/6055/46055v1-max-150x150.jpg"],[[250,58],"assets/images/resized/0004/6055/46055v1-max-250x250.jpg"],[[357,84],"assets/images/resized/0004/6055/46055v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"INKEF Capital","permalink":"inkef-capital","image":{"available_sizes":[[[150,44],"assets/images/resized/0018/8915/188915v1-max-150x150.jpg"],[[250,74],"assets/images/resized/0018/8915/188915v1-max-250x250.jpg"],[[259,77],"assets/images/resized/0018/8915/188915v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"Nijenborgh 4","address2":"9747 AG Groningen","zip_code":"","city":"","state_code":null,"country_code":"NLD","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,121],"assets/images/resized/0022/2921/222921v1-max-150x150.jpg"],[[250,202],"assets/images/resized/0022/2921/222921v1-max-250x250.jpg"],[[450,364],"assets/images/resized/0022/2921/222921v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}